Pigmentation Disorders Treatment Global Market Report 2024

The pigmentation disorders treatment market size has grown strongly in recent years. It will grow from $5.63 billion in 2023 to $6.14 billion in 2024 at a compound annual growth rate (CAGR) of 8.9%. The growth observed in the historical period can be attributed to factors such as the development of topical treatments, advancements in dermatology, the increased use of sunscreen and sun protection, the adoption of chemical exfoliation methods, and growing consumer awareness and education regarding pigmentation disorders and their treatment.

The pigmentation disorders treatment market size is expected to see strong growth in the next few years. It will grow to $8.33 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The anticipated growth in the forecast period can be attributed to factors such as enhanced delivery systems for pigmentation disorder treatments, the adoption of microbiome-based therapies, the integration of regenerative medicine, the rise in telemedicine services for dermatological care, and the increasing use of gene therapy and biologics in skincare. Major trends expected in the forecast period encompass the implementation of skin health education programs, the development of bio-inspired skincare solutions, the advancement of non-invasive treatment modalities, the emergence of neurocosmetics and psychodermatology, and the establishment of legal regulations and safety standards in the field of pigmentation disorder treatments.

The pigmentation disorder treatment market is anticipated to experience substantial growth, driven by the increasing prevalence of pigmentation disorders. These disorders involve abnormal or uneven coloring of the skin, hair, or eyes, resulting from factors such as genetics, hormonal changes, sun exposure, or underlying medical conditions. Various treatment approaches, including topical medications, laser therapy, chemical peels, and microdermabrasion, aim to reduce or lighten dark spots associated with conditions such as albinism, melasma, vitiligo, or hyperpigmentation. For example, a June 2021 report from the Office of the United Nations High Commissioner for Human Rights highlighted the prevalence of albinism in Europe and North America, estimating it to range between 1 in 17,000 and 1 in 20,000. Regions such as the Netherlands and Northern Ireland reported even higher prevalence rates. Thus, the increasing occurrence of pigmentation disorders propels the growth of the pigmentation disorder treatment market.

The substantial growth of disposable incomes worldwide is a significant contributor to the expansion of the pigmentation disorder treatment market. Rising disposable incomes, particularly in developing regions, empower individuals to allocate more resources to cosmetic and dermatological treatments. Data from October 2023 published by the Bureau of Economic Analysis revealed an increase in Americans' disposable income from $18,247.8 billion in the first quarter of 2022 to $19,880.2 billion in the first quarter of 2023. Consequently, the global rise in disposable incomes is expected to drive the pigmentation disorders treatment market.

A noteworthy trend in the pigmentation disorder treatment market is the integration of technological advancements. Major companies in this market are focusing on developing innovative products utilizing advanced technologies to enhance their market position. For instance, Scientis SA introduced the Cyspera Intensive System in March 2022, a comprehensive solution leveraging dual chamber technology. This system incorporates key ingredients such as Cysteamine Isobionic-Amid Complex, AHA-Amino Acid Complex, and Isobionic-Amide Complex, effectively addressing hyperpigmentation by delivering potent antioxidant activity, balancing skin pH, and providing anti-inflammatory benefits.

Companies operating in the pigmentation disorder treatment market are also placing emphasis on the development of nutricosmetics products. The integration of nutricosmetics involves using oral supplements to improve skin health and is gaining popularity. Nutrients such as antioxidants and vitamins are promoted for their potential benefits to pigmentation and overall skin condition. For instance, in March 2023, Symrise AG launched diana food bioactives, a collection of innovative nutricosmetic ingredients designed for 'Beauty from within' products. The collection includes solutions for skin conditioning, anti-aging, skin brightening, and hair and nail care, contributing to the expanding field of cosmetic ingredients.

In December 2021, DermBiont Inc. strategically acquired Chroma Dermatology, marking a notable development in the pigmentation disorder treatment market. This acquisition broadens DermBiont's portfolio to include the management of various skin conditions, including hyperpigmentation disorders such as melasma and solar lentigos, as well as other dermatological conditions such as seborrheic keratosis, atopic dermatitis, seborrheic dermatitis, and acne.

Major companies operating in the pigmentation disorders treatment market report are AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb, L’Oréal S.A., Astellas Pharma Inc., Bausch Health Companies Inc., Bayer AG, Strides Pharma Science Limited, Galderma S.A., Incyte Corporation, Panacea Biotec Ltd., Dr. Reddy's Laboratories Ltd., Laboratories Pierre Fabre, Glenmark Pharmaceuticals Limited., Dermavant Sciences Inc., Lumenis Be Ltd., Accord Healthcare, Obagi Medical Products Inc., Fotona d.o.o., Sesderma SL, DermaMed Solutions LLC., Vital Esthetique, Vivier Pharma, Arcutis Biotherapeutics, Episciences Inc., Phio Pharmaceuticals Inc., Scientis SA, Philadelphia Pharmaceutical.

North America was the largest region in the pigmentation disorders treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pigmentation disorders treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pigmentation disorders treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The main types of pigmentation disorder treatments include topical treatment, dermabrasion, chemical peels, laser treatment, phototherapy, and others. Topical treatments involve the application of medications or products directly to the skin's surface to address various skin conditions, including pigmentation disorders. The treatment of pigmentation disorders utilizes various drugs such as calcineurin inhibitors, melanocyte-stimulating hormones, and others to address conditions such as albinism, vitiligo, melasma, post-inflammatory hyperpigmentation (PIH), and more. These drugs can be administered through oral, topical, and other routes and are distributed through dermatology clinics, aesthetic clinics, drugstores and cosmetic stores, e-commerce platforms, and other channels.

The pigmentation disorders treatment research report is one of a series of new reports that provides pigmentation disorders treatment market statistics, including the pigmentation disorders treatment industry's global market size, regional shares, competitors with a pigmentation disorders treatment market share, detailed pigmentation disorders treatment market segments, market trends and opportunities, and any further data you may need to thrive in the pigmentation disorders treatment industry. This pigmentation disorders treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pigmentation disorders treatment market consists of revenues earned by entities by providing pigmentation disorders treatment services such as cryotherapy, light therapy, and depigmentation. The market value includes the value of related goods sold by the service provider or included within the service offering. The pigmentation disorder treatment market also includes sales of topical creams and serums, micro needling devices, and light therapy devices that are used in pigmentation disorder treatments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.